Literature DB >> 9443848

Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults.

M Ashton1, T N Hai, N D Sy, D X Huong, N Van Huong, N T Niêu, L D Công.   

Abstract

The pharmacokinetics of the antimalarial artemisinin exhibited an unusual time dependency during a 7-day oral daily regimen of 500 mg in 10 healthy, male Vietnamese adults. Artemisinin areas under the plasma concentration-time curve (AUC) decreased to 34% (median) by day 4 with a further decrease by day 7 to only 24% of values obtained after the first day of administration. In seven subjects restudied after a 2-week washout period, artemisinin AUCs had almost normalized, demonstrating the reversibility of the time-dependent drug disposition. The results suggest artemisinin exhibits an auto-inductive effect on drug metabolism of an unusual magnitude. This may partly explain why some patients on standard doses, due to subparasiticidal drug levels toward the end of a standard regimen, do not completely clear parasites. Further, the possibility of drug-drug metabolic interactions during combination regimens is implicated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443848

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  43 in total

1.  Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers.

Authors:  Timothy M E Davis; Michelle England; Anne-Marie Dunlop; Madhu Page-Sharp; Nathalie Cambon; Thomas G Keller; János L Heidecker; Kenneth F Ilett
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

Review 2.  Pregnane X receptor and natural products: beyond drug-drug interactions.

Authors:  Jeff L Staudinger; Xunshan Ding; Kristin Lichti
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

Review 3.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Retrospective analysis of artemisinin pharmacokinetics: application of a semiphysiological autoinduction model.

Authors:  Sara Asimus; Toufigh Gordi
Journal:  Br J Clin Pharmacol       Date:  2007-06       Impact factor: 4.335

5.  Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.

Authors:  Toufigh Gordi; Rujia Xie; William J Jusko
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

6.  Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.

Authors:  F Ezzet; R Mull; J Karbwang
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 7.  Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

Authors:  B K Park; P M O'Neill; J L Maggs; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

8.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

9.  Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.

Authors:  Beesan Tan; Himanshu Naik; In-Jin Jang; Kyung-Sang Yu; Lee E Kirsch; Chang-Sik Shin; J Carl Craft; Lawrence Fleckenstein
Journal:  Malar J       Date:  2009-12-18       Impact factor: 2.979

10.  Quantification of artemisinin in human plasma using liquid chromatography coupled to tandem mass spectrometry.

Authors:  N Lindegardh; J Tarning; P V Toi; T T Hien; J Farrar; P Singhasivanon; N J White; M Ashton; N P J Day
Journal:  J Pharm Biomed Anal       Date:  2008-12-24       Impact factor: 3.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.